130 related articles for article (PubMed ID: 2863022)
1. Importance of endogenous vasopressin in the hypertensive and bradycardic response to central alpha 1-adrenergic stimulation.
Hiwatari M; Johnston CI
Clin Exp Pharmacol Physiol; 1985; 12(3):221-5. PubMed ID: 2863022
[TBL] [Abstract][Full Text] [Related]
2. Involvement of vasopressin in the cardiovascular effects of intracerebroventricularly administered alpha 1-adrenoceptor agonists in the conscious rat.
Hiwatari M; Johnston CI
J Hypertens; 1985 Dec; 3(6):613-20. PubMed ID: 2868056
[TBL] [Abstract][Full Text] [Related]
3. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the implication of endogenous vasopressin in cardiovascular response to central alpha-adrenoceptor stimulation.
Hiwatari M; Abe K; Imai Y; Yoshinaga K; Johnston CI
Jpn Circ J; 1986 Nov; 50(11):1149-54. PubMed ID: 3029447
[TBL] [Abstract][Full Text] [Related]
5. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats.
Kawasaki H; Takasaki K
Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):217-33. PubMed ID: 2892472
[TBL] [Abstract][Full Text] [Related]
6. The differential cardiovascular response to centrally administered carbachol seen in Brattleboro and normal Long-Evans rats.
Imai Y; Sasaki S; Minami N; Munakata ; Sekino H; Abe K; Yoshinaga K
Clin Exp Hypertens A; 1988; 10 Suppl 1():323-30. PubMed ID: 3242998
[TBL] [Abstract][Full Text] [Related]
7. Paraventricular nucleus injections of noradrenaline: cardiovascular effects in conscious Long-Evans and Brattleboro rats.
Harland D; Gardiner SM; Bennett T
Brain Res; 1989 Sep; 496(1-2):14-24. PubMed ID: 2553199
[TBL] [Abstract][Full Text] [Related]
8. Central vasopressin impairs the baroreceptor heart rate reflex in conscious rats.
Brattström A; de Jong W; De Wied D
J Cardiovasc Pharmacol; 1990 Jan; 15(1):114-7. PubMed ID: 1688967
[TBL] [Abstract][Full Text] [Related]
9. Endogenous vasopressin modulates the baroreflex sensitivity in rats.
Imai Y; Nolan PL; Johnston CI
Clin Exp Pharmacol Physiol; 1983; 10(3):289-92. PubMed ID: 6627742
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with vasodilator or V1-antagonist abolishes vasopressin withdrawal hypotension in spontaneously hypertensive rats.
Chiu EK; McNeill JR
J Hypertens; 1987 Oct; 5(5):593-8. PubMed ID: 2963065
[TBL] [Abstract][Full Text] [Related]
11. Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats.
Harland D; Gardiner SM; Bennett T
Circ Res; 1989 Oct; 65(4):925-33. PubMed ID: 2791228
[TBL] [Abstract][Full Text] [Related]
12. Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition.
Rettig R; Geist R; Sauer U; Rohmeiss P; Unger T
Am J Physiol; 1989 Sep; 257(3 Pt 2):R588-94. PubMed ID: 2571303
[TBL] [Abstract][Full Text] [Related]
13. Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism.
Thornhill J; Gregor L; Pittman Q
Regul Pept; 1990 Oct; 31(1):1-10. PubMed ID: 1980152
[TBL] [Abstract][Full Text] [Related]
14. Evaluation for roles of brain prostaglandins in the catecholamine-induced vasopressin secretion in conscious rats.
Yamaguchi K; Hama H
Brain Res; 1993 Apr; 607(1-2):149-53. PubMed ID: 8386972
[TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular treatment with vasopressin V1-receptor antagonist inhibits centrally-mediated pressor response to clonidine in conscious rats.
Nakamura S; Kawasaki H; Takasaki K
Jpn J Pharmacol; 1993 Dec; 63(4):447-53. PubMed ID: 8121079
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
17. Role of vasopressin in cardiovascular response to central cholinergic stimulation in rats.
Imai Y; Abe K; Sasaki S; Minami N; Munakata M; Yumita S; Nobunaga T; Sekino H; Yoshinaga K
Hypertension; 1989 Jun; 13(6 Pt 1):549-57. PubMed ID: 2737706
[TBL] [Abstract][Full Text] [Related]
18. Role of AVP in pressor responses during activation of central TxA2/PGH2 receptors.
Wilcox CS; Gao H; Verbalis JG; Welch WJ
Am J Physiol; 1997 Oct; 273(4):H1927-32. PubMed ID: 9362262
[TBL] [Abstract][Full Text] [Related]
19. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
Maione S; Vitagliano S; Berrino L; Lampa E; Rossi F
Neuropharmacology; 1992 Apr; 31(4):403-7. PubMed ID: 1355901
[TBL] [Abstract][Full Text] [Related]
20. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
Goering J; Zimmerman BG
J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
